Global Life Science Tools Market Tour and Analysis, 2020-2022 and 2027 – ResearchAndMarkets.com

DUBLIN – (BUSINESS THREAD) – “Life Science Tools – Global Market Trajectory & Analytics” report added At ResearchAndMarkets.com offer.

The Global Life Sciences Marketplace will reach $ 183.8 billion by 2027

In the midst of the COVID-19 crisis, the global life sciences market will have $ 89.4 trillion by 2020. It will review $ 183.8 trillion by 2027, a CAGR growth of 10.8% over the 2020 analysis period. -2027.

Cell Biology, one of the segments analyzed in the report, is expected to grow at a CAGR of 9.9% to reach $ 71.3 billion by the end of the analysis period.

After an early analysis of the business consequences of the pandemic and the resulting economic crisis, the growth of the Genomics segment is adjusted to a revised CAGR of 10.9% over the next 7 years. This segment currently accounts for 20.6% of the global life sciences market.

The US accounts for more than 37.2% of the global market in 2020, while China is projected to grow at a CAGR of 16.2% for the period 2020-2027.

The US Life Sciences Instruments market is expected to reach $ 33.3 trillion by 2020. The country currently has a 37.21% share of the global market. China, the world’s second-largest economy, is projected to reach a market size of $ 20.3 trillion by 2027 by 2027, after a 16.2% CAGR by 2027.

Other notable geographic markets include Japan and Canada, which are forecast to grow by 8.4% and 10.1%, respectively, over the period 2020-2027. In Europe, Germany is projected to grow at a CAGR of approximately 10%, and the rest of Europe’s markets (as determined in the study) will reach $ 20.3 trillion by 2027.

The proteomics segment has a share of 22.4% in 2020

In the global proteomics segment, the US, Canada, Japan, China and Europe will drive an estimated CAGR of 12.4% for this segment. These combined markets with a combined market size of $ 16.6 billion in 2020 will reach the projected size of $ 37.6 billion by the end of the analysis period.

China will continue to be among the fastest growing in this set of regional markets. Led by countries such as Australia, India and South Korea, the Asia-Pacific market is projected to reach $ 20.3 trillion by 2027.

What’s new for 2022?

  • Global competitiveness and major market shares of competitors

  • Market presence in different geographies – Strong / Active / Niche / Trivial

  • Personalized peer-to-peer collaboration updates online

  • Access to the publisher’s digital archive and Research Platform

  • Free updates for one year

Main topics covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET VIEW

  • Influence of COVID-19 on the Life Sciences Sector

  • Competitive market presence – strong / active / niche / insignificant for 33 players around the world in 2022 (E)

  • Recent market activity

  • World Brands

  • Life Science Tools: A Prelude

  • Market forecast

  • Cell biology plays an important role in revenue

  • Factors related to major implications for the Life Sciences Domain and related tools

2. NUMBER THESE PLAYERS (308 total highlights)

  • Abbott Laboratories Inc.

  • Agilent Technologies, Inc.

  • Becton, Dickinson and Company

  • Bio-Rad Laboratories, Inc.

  • Bruker Corporation

  • Carl Zeiss AG

  • Eppendorf SE

  • F. Hoffmann-La Roche AG

  • Hitachi High-Tech Corporation

  • Illumina, Inc.

  • Merck KGaA

  • Oxford Instruments plc

  • PerkinElmer Inc.

  • QIAGEN NV

  • Shimadzu Corporation

  • Thermo Fisher Scientific Inc.

3. MARKET TRENDS AND ACTORS

  • Trends in the demand for Life Science Research Support

  • 3D Cell Culture Transforms the Life Sciences Industry

  • Increasing demand for 3D cell culture in drug discovery

  • Using 3D cell culture for regenerative medicine

  • Proteomics appears to be an important research tool in the fight against COVID-19

  • The need for COVID-19 Diagnosis and Therapeutics highlights the dynamic role of Proteomics

  • Proteomics profiles to accelerate drug discovery

  • Proteomics, with the latest advances

  • Mass Spectrometry (MS) extends the application of Proteomics

  • AI and Machine Learning address the shortcomings of traditional equipment to effectively identify protein patterns

  • mRNA Technology stands out in the Life Sciences

  • Instrumentation innovations have expanded functionality and boosted PCR acceptance

  • A synoptic review of the technical advances in quantitative PCR in recent years

  • Greater Integration of Genomic Technologies in the Development of New Diagnostic Tests

  • Next-generation sequencing drives market growth

  • R&D activity is still alive in NGS

  • The Need for Large-Scale NGS Data Analysis Drives Cloud-Enabled Bioinformatics Services

  • Ready for the emergence of single-cell space biology technologies as an integral part of future laboratories.

  • Applications of genome-wide sequencing are on the rise in demand for faster secondary analysis tools

  • Rapid growth of the biopharmaceutical industry and increased investment in R&D to boost market outlook

  • Liquid chromatography is driving growth in new application markets

  • Innovative HPLC products are injecting new growth

  • Digital Transformation in the Life Sciences Sector Improves Efficiency and Productivity

  • The main initiators of the Digital Transformation in the Life Sciences

  • R&D spending in the Pharmaceutical and Biotechnology Sectors offers increasing opportunities

  • Dissemination of technological developments and end-use applications to promote the growth of Mass Spectrometry

  • Miniature mass spectroscopy instruments are well known

  • Increasing health spending to boost demand for Life Science tools

4. A GLOBAL MARKET VIEW

III. REGIONAL MARKET ANALYSIS

IV. COMPETITION

For more information on this report, visit https://www.researchandmarkets.com/r/aecziv

Leave a Comment